carbapenems has been researched along with Inflammatory Response Syndrome, Systemic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, J; Mukhopadhyay, A; Tambyah, PA; Vasudevan, A; Yuen, EG | 1 |
Bass, SN; Bauer, SR; Lam, SW; Neuner, EA | 1 |
Belkina, IuE; Bondarenko, IV; Ivanova, OV; Kirsanov, AI; Panasenko, VV; Sleptsov, VP; Stepkina, OI; Usachenko, VP | 1 |
3 other study(ies) available for carbapenems and Inflammatory Response Syndrome, Systemic
Article | Year |
---|---|
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Critical Illness; Cross Infection; Decision Support Techniques; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis; Risk Factors; Surgical Procedures, Operative; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 2014 |
Impact of combination antimicrobial therapy on mortality risk for critically ill patients with carbapenem-resistant bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Critical Illness; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Survival Rate; Systemic Inflammatory Response Syndrome | 2015 |
[Experience of application of meronem in the treatment of severe purulent sepsis in children].
Topics: Adolescent; Carbapenems; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Meropenem; Severity of Illness Index; Systemic Inflammatory Response Syndrome; Thienamycins | 2002 |